Location History:
- Kruishoutem, BE (2009)
- Wannegem-Lede, BE (2014 - 2021)
Company Filing History:
3 out of 489 
2 out of 223 
1 out of 1 Years Active: 2009-2021
Title: Steven Geysens: Innovator in Glyco-Engineering
Introduction
Steven Geysens is a notable inventor based in Wannegem-Lede, Belgium. He has made significant contributions to the field of glyco-engineering, holding a total of 4 patents. His work focuses on the development of eukaryotic cells that can produce glycoproteins with altered glycosylation patterns, which has important implications for protein production and disease treatment.
Latest Patents
One of his latest patents is titled "Cells producing glycoproteins having altered glycosylation patterns and method and use thereof." This invention relates to eukaryotic cells that contain both an endoglucosaminidase and a glycoprotein. These cells can deglycosylate or partially deglycosylate exogenous glycoproteins without the need for additional enzymes. Another significant patent is for the "Human alpha-N-acetylgalactosaminidase polypeptide," which provides new forms of the NAGAL polypeptide and its variants. This invention has potential applications in treating Fabry disease, Schindler disease, and Kanzaki disease.
Career Highlights
Throughout his career, Steven Geysens has worked with esteemed institutions such as Ghent University and VIB (Flanders Institute for Biotechnology). His research has contributed to advancements in glyco-engineering and has positioned him as a key figure in this innovative field.
Collaborations
Steven has collaborated with notable colleagues, including Nico L M Callewaert and Karen De Pourcq. Their combined expertise has furthered research and development in glyco-engineering.
Conclusion
Steven Geysens is a prominent inventor whose work in glyco-engineering has led to significant advancements in the production of glycoproteins and potential treatments for various diseases. His contributions continue to impact the field positively.